Angela Casini

Active 2000–2024

124
Papers
17,936
Citations
78
h-index
122
i10-index

Citations

Citations per year for Angela Casini1995: 3 citations2001: 2 citations2002: 5 citations2003: 20 citations2004: 96 citations2005: 98 citations2006: 92 citations2007: 108 citations2008: 130 citations2009: 163 citations2010: 145 citations2011: 224 citations2012: 245 citations2013: 207 citations2014: 193 citations2015: 178 citations2016: 117 citations2017: 167 citations2018: 158 citations2019: 474 citations2020: 538 citations2021: 466 citations2022: 415 citations2023: 310 citations2024: 565 citations2025: 274 citations2026: 3 citations1996–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 751 citing papers, 14.8% of this breakdownItaly: 682 citing papers, 13.5% of this breakdownUnited States: 540 citing papers, 10.7% of this breakdownIndia: 265 citing papers, 5.2% of this breakdownGermany: 228 citing papers, 4.5% of this breakdownUnited Kingdom: 221 citing papers, 4.4% of this breakdownFrance: 176 citing papers, 3.5% of this breakdownSpain: 161 citing papers, 3.2% of this breakdownSwitzerland: 132 citing papers, 2.6% of this breakdownTürkiye: 123 citing papers, 2.4% of this breakdownSaudi Arabia: 106 citing papers, 2.1% of this breakdownPortugal: 99 citing papers, 1.9% of this breakdown
0%14.8%Other 31.2%

Fields

  • Medicine35.8%
  • Biochemistry, Genetics and Molecular Biology34.7%
  • Chemistry11.3%
  • Nursing5.6%
  • Materials Science3.6%
  • Computer Science2.9%
  • Other6.1%

Topics

  • Metal complexes synthesis and properties10%
  • Enzyme function and inhibition6.8%
  • Ferrocene Chemistry and Applications4%
  • Trace Elements in Health3.5%
  • Synthesis and Catalytic Reactions3.3%
  • Click Chemistry and Applications2.4%
  • Other70%

Coauthors

All papers

Open in search
  1. Connecting copper and cancer: from transition metal signalling to metalloplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature reviews. Cancer 2021 cited by 1,273

  2. Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

    Authors: , , , , , - Coordination Chemistry Reviews 2009 cited by 585

  3. Carbonic anhydrase inhibitors

    Authors: , , - Medicinal Research Reviews 2002 cited by 1,441

  4. Metals in Cancer Research: Beyond Platinum Metallodrugs

    Authors: , - ACS Central Science 2024 cited by 118

  5. Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies

    Authors: , , , , , - Medicinal Research Reviews 2009 cited by 499

  6. Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management

    Authors: , , , , , , - International Journal of Pharmaceutics 2021 cited by 57

  7. Interfering with Metabolic Profile of Triple‐Negative Breast Cancers Using Rationally Designed Metformin Prodrugs

    Authors: , , , , , , , , , , , , , , - Angewandte Chemie International Edition 2021 cited by 69

  8. Exploring the Anticancer Activity of Tamoxifen-Based Metal Complexes Targeting Mitochondria

    Authors: , , , , , , , , , - Journal of Medicinal Chemistry 2023 cited by 42

  9. A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds

    Authors: , - Dalton Transactions 2013 cited by 440

  10. Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pH

    Authors: , , , , , , , , , , - FEBS Letters 2004 cited by 707

  11. Cellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin

    Authors: , , - Molecules 2014 cited by 183

  12. 7. MEDICINAL CHEMISTRY OF GOLD ANTICANCER METALLODRUGS

    Authors: , , - Metallo-Drugs: Development and Action of Anticancer Agents 2018 cited by 165

  13. Aquaporin-3 is involved in NLRP3-inflammasome activation contributing to the setting of inflammatory response

    Authors: , , , , , - Cellular and Molecular Life Sciences 2020 cited by 53

  14. Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs

    Authors: , , , , - Chemical Society Reviews 2013 cited by 152

  15. Sulfonamides and Sulfonylated Derivatives as Anticancer Agents

    Authors: , , , - Current Cancer Drug Targets 2002 cited by 293

  16. Mass spectrometry as a powerful tool to study therapeutic metallodrugs speciation mechanisms: Current frontiers and perspectives

    Authors: , - Coordination Chemistry Reviews 2017 cited by 114

  17. Characterization of CA XIII, a Novel Member of the Carbonic Anhydrase Isozyme Family

    Authors: , , , , , , , , , , , - Journal of Biological Chemistry 2004 cited by 261

  18. Caffeine-Based Gold(I) N-Heterocyclic Carbenes as Possible Anticancer Agents: Synthesis and Biological Properties

    Authors: , , , , , , , , , , , - Inorganic Chemistry 2014 cited by 236

  19. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches

    Authors: , , , , , , , , , - Inorganic Chemistry 2017 cited by 99

  20. Design Strategies and Medicinal Applications of Metal-Peptidic Bioconjugates

    Authors: , - Bioconjugate Chemistry 2020 cited by 54

  21. Unexpected Nanomolar Inhibition of Carbonic Anhydrase by COX-2-Selective Celecoxib: New Pharmacological Opportunities Due to Related Binding Site Recognition

    Authors: , , , , , , - Journal of Medicinal Chemistry 2003 cited by 454

  22. The Promise of Self-Assembled 3D Supramolecular Coordination Complexes for Biomedical Applications

    Authors: , , - Inorganic Chemistry 2017 cited by 230

  23. Next-Generation Anticancer Metallodrugs

    Authors: , - Current Topics in Medicinal Chemistry 2012 cited by 214

  24. Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds

    Authors: , - Current Topics in Medicinal Chemistry 2011 cited by 199